Category: Hematology / Myeloproliferative Neoplasm
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, extramedullary hematopoiesis, splenomegaly, and progressive cytopenias, leading to debilitating symptoms and a shortened life expectancy.
Approximately 0.5-1.5 cases per 100,000 population per year, according to the MPN Research Foundation.
Discover the latest clinical trials and treatments for Myelofibrosis on JourneyForHealth.
View Full Analysis